Skip Navigation
Bookmark and Share
.
Clinical Decision Making
Clinical Decision Making
Prescription drugs are prescribed during clinical encounters. Thorough and effective patient-provider communication about the benefits, risks, costs and alternatives to prescription medicines is a vital part of clinical care. The Center supports research and advocacy to identify and overcome barriers to patient-provider communication to improve safe medication use and to maximize adherence.
Comparative Effectiveness
Comparative Effectiveness
For stakeholders to make informed decisions about prescription drug use, they need timely evidence about the comparative effectiveness of therapies and their alternatives, including their risks and benefits. Incomplete evidence contributes to overuse of some therapies, underuse of others and risky prescribing. The Center supports innovative research into these topics.
Global Medicines
Global Medicines
Ensuring adequate access and affordability of prescription medicines poses major and unique challenges for countries around the world. These challenges are particularly salient in emerging economies that account for an increasing proportion of the world's population and pharmaceutical expenditures. Center investigators focus on how public policy can be optimized to maximize global drug availability and access.
Medication Safety
Medication Safety
Some adverse effects of medicines only come to light after medications have been on the market and widely used. Center investigators are working to develop new methods for identifying risk, to predict the likelihood of high-risk medicines or drug combinations and to protect the public from excessive exposure to these products.
Policy Analyses
Policy Analyses
Complex and dynamic policies govern prescription drug regulation. Policymakers face the challenge of maximizing innovation while protecting public health, and developing payment policies that promote evidence-based usage. Center investigators evaluate regulatory policies to provide policymakers with information to continually optimize pharmaceutical regulation.
Prescription Abuse
Prescription Abuse
Prescription drugs provide therapeutic value to millions of Americans. At the same time, rates of prescription drug abuse and overdose deaths are skyrocketing. The annual number of fatal drug overdoses in the United States now surpasses those of motor vehicle deaths. The Center supports innovative research and public advocacy to help stem this epidemic.

Global Network for Access to Medicines

The mission of this working group is to learn about major challenges and gaps in global access to medicines while creating awareness about these issues within the School of Public Health and broader community. Our primary objective is to increase awareness around issues concerning quality and equitable access to medicines. To achieve this goal we are creating a network for students and professionals throughout Maryland, Virginia and Washington DC to increase exposure to innovation and research regarding access to medicines.

Previous Conferences

Safeguarding Quality in the Global Medicine Supply Chain

In April 2014, the CDSE, in conjunction with the Department of International Health, co-sponsored the second Global Access to Medicine’s Conference in an effort to bring together government entities, implementers, private sector players, regulatory bodies, consulting firms and advocacy groups in order to discuss the problem of poor quality medicines in both developing countries and United States’ markets. Panelists from the NIH, Management Sciences for Health, United States Pharmacopeia, Public Citizen, and the Alliance for Safe Online Pharmacies provided their expert opinions on issues involving security, technical implementation, regulation and policy and other challenges, approaches and solutions to safeguarding quality in the online drug market. 

Find a detailed agenda here
 

Medicines Shouldn't be a Luxury

In April 2013, the CDSE co-sponsored the first Global Access to Medicine's Conference. Panelists representing the World Bank, Clinton Health Initiative, Results 4 Development, US Agency for International Development, Public Citizen, Management Sciences for Health, and Amrita Therapeutics discussed the numerous challenges of access to medicine around the world, including:

  • Identifying grand challenges and gaps in access to medicines
  • Identifying pathways to improving access to medicines
  • Identifying potential future partnerships and formalizing a network on access to medicines at Hopkins

Find a detailed agenda here
 


For more information about the Global Network on Access to Medicines, please contact Gaurvika Nayyar.

Websites to learn about issues relating to access to medicines:

Access to Medicines Index
WHO Access to Medicines Statement
Quality Issues Delivering Medicine
 



 

johns hopkins

.
Subscribe:
  • Receive our Johns Hopkins
    Public Health Magazine,
    Public Health News
.